Top Medical News

COVID-19 Stressors Associated With Poorer Mental Health in Parkinson Disease

September 17, 2021

By Abby Reinhard

Data from the PRIME-NL study showed stressors resulting from the pandemic impacted depression, anxiety, and quality of life.

NeurologyLive Friday 5 — September 17, 2021

September 17, 2021

By NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending September 17, 2021.

Opicapone Demonstrates Small Benefit for Sleep in Parkinson Disease

September 17, 2021

By Marco Meglio

Improvements in mean total amount of time and percentage of participants that were awake suggested limited effect with opicapone (Ogentys; Neurocrine Bio).

ND0612 Subcutaneous Levodopa Delivery System Demonstrates Efficacy in Phase 2 Setting

September 17, 2021

By Marco Meglio

Patients with Parkinson disease in both the 24-hour and 16-hour ND0612 dosing regimen groups had ON-state UPDRS-motor scores and UPDRS-ADL scores improve over the 12-month period.

Trends in Migraine: COVID’s Impact and Barriers to Treatment

September 16, 2021

By Matt Hoffman

Deena Kuruvilla, MD, director, Westport Headache Institute, offered her insight into the trends in the clinical care of migraine and the effect that the pandemic has had on patients.


Latest Videos

Most Recent